Sign in
4

Changes in Ownership

ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-20-000049

Options or other derivatives

  • Sr. VP, New Product Dev. acquired 65,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kieffer Tara Lynn · Sr. VP, New Product Dev.

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-12-07 Grant or award : show line 1 in the form Stock Option (right to buy) +65,000 65,000 D
Loading xslF345X03/edgar.xml…